What is the primary purpose of the newly launched BioXPro series?

It is designed as a series of highly purified amino acids to support stable biopharmaceutical manufacturing and formulation processes.

Who are the partners involved in the development of the BioXPro series?

The series is designed by combining Croda's purification technology with insights gained through a partnership with Amino GmbH.

Which pharmacopoeias do the BioXPro series amino acids comply with?

They comply with major pharmacopoeias in Japan, the United States, Europe, and China.

In which process areas can the BioXPro series be utilized?

They can be used in cell culture media design, viral inactivation, purification, and final formulation stabilization.

AI News NQ Analysis

Croda Launches "BioXPro™" Advanced Purified Amino Acid Series to Support Stable Biopharmaceutical Manufacturing and Formulation Processes

NQ Score 75/100

N1 Content Completeness 8

AI Summary (NQ-processed)

Croda Japan Co., Ltd. has launched "BioXPro™", a series of highly purified amino acids designed as excipients for biopharmaceuticals. This product line aims to stabilize manufacturing and formulation processes by reducing variability originating from raw materials. BioXPro™ combines Croda's purification technology with expertise from Amino GmbH, ensuring low levels of metals, elemental impurities, and endotoxins. The series includes four types: Arginine, Arginine Hydrochloride, Histidine, and Histidine Hydrochloride, complying with major pharmacopoeias in Japan, the US, Europe, and China. It is suitable for various applications from R&D to commercial scale, including cell culture, viral inactivation, purification, pH adjustment, buffering, stabilization, and viscosity reduction in final formulations. Croda will showcase BioXPro™ and other products at CPHI Japan 2026 in Tokyo Big Sight from April 21-23, 2026.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary purpose of the newly launched BioXPro series?: A: It is designed as a series of highly purified amino acids to support stable biopharmaceutical manufacturing and formulation processes.
Q: Who are the partners involved in the development of the BioXPro series?: A: The series is designed by combining Croda's purification technology with insights gained through a partnership with Amino GmbH.
Q: What are the four types of amino acids offered in the BioXPro series lineup?: A: The series offers Arginine, Arginine Hydrochloride, Histidine, and Histidine Hydrochloride.
Q: Which pharmacopoeias do the BioXPro series amino acids comply with?: A: They comply with major pharmacopoeias in Japan, the United States, Europe, and China.
Q: In which process areas can the BioXPro series be utilized?: A: They can be used in cell culture media design, viral inactivation, purification, and final formulation stabilization.